Can Lin
Chongqing, 400030, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Development and multicenter validation of an AI-driven detection system for DLBCL cells in bone marrow smears.
Journal: Scientific reports
Published: February 12, 2026
Exosomes liquid biopsy in Lymphoma precision medicine: applications and challenges.
Journal: Cancer cell international
Published: December 25, 2025
Engineered red blood cell extracellular vesicles for delivery of Dox and siIDO1 enhance targeted chemo-immunotherapy of acute myeloid leukemia.
Journal: Journal for immunotherapy of cancer
Published: June 28, 2025
The Characteristics of Peripheral Blood Lymphocyte Subsets in HIV-related Diffuse Large B-cell Lymphoma Patients and Their Impact on Treatment Efficacy.
Journal: Current HIV research
Published: November 30, 2024
Engineered cell membrane vesicles loaded with lysosomophilic drug for acute myeloid leukemia therapy via organ-cell-organelle cascade-targeting.
Journal: Biomaterials
Published: July 23, 2024
Cytoplasmic TP53INP2 acts as an apoptosis partner in TRAIL treatment: the synergistic effect of TRAIL with venetoclax in TP53INP2-positive acute myeloid leukemia.
Journal: Journal of experimental & clinical cancer research : CR
Published: March 30, 2024
Cytoplasmic Expression of TP53INP2 Modulated by Demethylase FTO and Mutant NPM1 Promotes Autophagy in Leukemia Cells.
Journal: International journal of molecular sciences
Published: November 23, 2022
Circulating plasma exosomal long non-coding RNAs LINC00265, LINC00467, UCA1, and SNHG1 as biomarkers for diagnosis and treatment monitoring of acute myeloid leukemia.
Journal: Frontiers in oncology
Published: August 31, 2022
Targeted activation of GPER enhances the efficacy of venetoclax by boosting leukemic pyroptosis and CD8+ T cell immune function in acute myeloid leukemia.
Journal: Cell death & disease
Published: July 19, 2022
Mutant NPM1-Regulated FTO-Mediated m6A Demethylation Promotes Leukemic Cell Survival via PDGFRB/ERK Signaling Axis.
Journal: Frontiers in oncology
Published: November 18, 2021
Tumour-derived small extracellular vesicles suppress CD8+ T cell immune function by inhibiting SLC6A8-mediated creatine import in NPM1-mutated acute myeloid leukaemia.
Journal: Journal of extracellular vesicles
Published: July 04, 2021
Showing 1-11 of 11
Last Updated: 09/26/2026